Nightingale Health receives three new patents further strengthening its IP portfolio
Press release, 26 September 2023 at 9:00 a.m. (EEST)
Nightingale Health Plc (“Nightingale Health”), pioneer in health risk detection and preventative health, has received three new patent approvals from the Finnish Patent Authority. Nightingale Health announced on 23 May 2023 that it had received six patent approvals and with these three new patents the company’s patent portfolio expands to self-collected finger-prick blood samples and more disease areas.
The first of the newly received patents was granted for the company’s proprietary technology’s ability to determine with selected